Abstract:To realize dose deformation and accumulation using image registration technology, and evaluate the anatomic changes and corresponding dosimetric variations for patients with nasopharyngeal carcinoma (NPC). 15 patients with NPC treated with IMRT were selected in this study, the original treatment plan(Plan1(CT1)) based on the first CT scan(CT1) and the second plan(Plan2(CT2)) based on the repeated CT scan(CT2) were calculated using the planning system Raystation Version 4.5 (RaySearch Laboratories AB, Stockholm, Sweden). Plan1(CT2) was acquired by deforming the dose of Plan1(CT1) to CT2 using the hybrid deformation image registration method, which express to perform the original plan without re-planning. Assessing the dose distribution and deciding whether to modify the plan, if need it, Plan2(CT2) was planned based on CT2 images, Plan1+2(CT2) that expressing the actual exposure dose after modification was generated by accumulating the dose of Plan1(CT2) and Plan2(CT2). The dose distribution was compared among Plan1(CT1), Plan2(CT2) and Plan1+2(CT2). Compared with CT1, the volume of GTVnx, GTVnd and CTV2 in CT2 decreased by 36.3%, 36.3% and 49.8% respectively, and the left and right parotid gland decreased in volume by 34.6% and 34.6%. Compared with Plan1(CT1), due to the changes of organ size and location, the dose to target organ were significantly decreased in Plan1(CT2) (the dose received by 95% of the target (D95) to GTVnx, GTVnd and CTV2 were decreased by 2.9%, 6.2% and 3.3%, respectively), and the dose to normal tissue were increased (the dose to right parotid gland, brain stem and spinal cord were increased by 5.5%, 1.4% and 8.9%, respectively). With repeated CT and re-planning after 20 times as shown in Plan1+2(CT2), the dose delivered to target were significantly increased (Compared with Plan1(CT2), the dose in Plan1+2(CT2) received by 95% of the target (D95) to GTVnx, GTVnd and CTV2 were increased by 2.9%, 3.3% and 3.7%, respectively), and at the same time the dose to normal tissue were decreased as much as possible (the mean dose to the left and right parotid gland were decreased by 3.0% and 7.4%, and the max dose to the brain stem and spinal cord were decreased by 14.1% and 7.7%). During the course of adaptive radiotherapy, the volume of parotid gland and target significantly decreased. Re-planning after 20 times could ensure adequate dose to target and safe dose to the normal tissues.

<p>Comparative Study of Auto Plan and Manual Plan for Nasopharyngeal Carcinoma Intensity-Modulated Radiation Therapy [Corrigendum]</p>

Comparison of Quality of Life in Patients with Nasopharyngeal Carcinoma Receiving Conventional External Beam Radiation Therapy Versus Intensity Modulated Radiation Therapy

A Feedback Constraint Optimization Method for Intensity-Modulated Radiation Therapy of Nasopharyngeal Carcinoma

Corrigendum: Comparison of Clinical Outcomes Between Cone Beam CT-guided Thermal Ablation and Helical Tomotherapy in Pulmonary Metastases from Hepatocellular Carcinoma

Dosimetric Evaluation of Hippocampus Sparing Intensity Modulated Radiation Therapy in Patients with Stage T1-T2 and Stage T3-T4 Nasopharyngeal Carcinoma

SU‐FF‐T‐96: Clinical Study of the Necessity of Replanning IMRT Treatment for Patients with Nasopharyngeal Carcinoma

Anatomic and Dosimetric Changes During the Treatment Course of Intensity-Modulated Radiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Volumetric modulated arc therapy as an alternative to intensity modulated radiotherapy for primary tumors of advanced non small cell lung cancer: A multicenter retrospective analy sis based on propensity score matching

Feasibility of automatic plan using RapidPlan model in intensity-modulated radiotherapy plan for nasopharyngeal carcinoma

Automatic Planning for Nasopharyngeal Carcinoma Based on Progressive Optimization in RayStation Treatment Planning System

[Concurrent Control Study of Different Radiotherapy for Primary Nasopharyngeal Carcinoma: Intensity-Modulated Radiotherapy Versus Conventional Radiotherapy].

Study on dosimetric difference of organ at risk between actual estimated receiving and pretreatment plan during intensity-modulated radiotherapy for nasopharyngeal carcinoma

Dose Deformation and Accumulation for Adaptive Radiotherapy in Nasopharyngeal Carcinoma

Clinical Study of the Necessity of Replanning Before the 25th Fraction During the Course of Intensity-Modulated Radiotherapy for Patients with Nasopharyngeal Carcinoma

Omission of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Treated with Intensity Modulated Radiation Therapy: A Paired Cohort Study

A Method for Standardizing Intensity Modulated Radiation Therapy Planning Optimization for Nasopharyngeal Carcinoma

Treatment plan comparison of Linac step and shoot,Tomotherapy, RapidArc, and Proton therapy for prostate cancer using dosimetrical and biological index

Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Dosimetric Study of Lower Cranial Nerve after Conventional Radiotherapy in Patients with Nasopharyngeal Carcinoma

Corrigendum to: Progress of Angiogenesis Signal Pathway and Antiangiogenic Drugs in Nasopharyngeal Carcinoma

Changes of the Transverse Diameter and Volume and Dosimetry Before the 25th Fraction During the Course of Intensity-Modulated Radiation Therapy (imrt) for Patients with Nasopharyngeal Carcinoma

&lt;p&gt;Comparative Study of Auto Plan and Manual Plan for Nasopharyngeal Carcinoma Intensity-Modulated Radiation Therapy [Corrigendum]&lt;/p&gt;